Valar Labs’ CHAI Biomarkers Validated in New Study in European Urology for Predicting Outcomes of High Grade Ta Bladder Cancer
VLRLPALO ALTO, Calif.--(BUSINESS WIRE)--Valar Labs publishes new evidence in European Urology validating CHAI biomarkers for risk stratification of recurrence and progression
June 13, 2025Clinical
Read more →